Prosecution Insights
Prosecution Insights
47 pending office actions • 12 clients • 41 examiners • 23 art units • 0 of 47 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §101 + other | 4 (9%) |
| §103 only | 7 (15%) |
| §112 only | 7 (15%) |
| Double-patenting only | 3 (6%) |
| Double-patenting + other | 9 (19%) |
| Multi-statute (no §101) | 16 (34%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 2 | 40.3% | +50.7% |
| LEITH, NANCY J | 2 | 74.8% | +43.7% |
| PERSONS, JENNA L | 2 | 50.0% | +60.0% |
| STEADMAN, DAVID J | 2 | 57.7% | +29.5% |
| SCHLOOP, ALLISON ELIZABETH | 2 | 60.0% | +59.3% |
| RAMIREZ, DELIA M | 2 | 65.1% | +56.3% |
| KUCKLA, ANNA GRACE | 1 | 50.0% | +53.3% |
| GRAHAM, ANDREW D | 1 | 59.7% | +22.4% |
| WANG, XIAOBEI | 1 | 65.1% | +48.3% |
| ANDREWS, MICHAEL | 1 | 64.3% | +24.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688206 | STATOR WITH PERMANENT PROTECTIVE BARRIER SEALING | ANDREWS, MICHAEL | 70d overdue |
| 17786168 | GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES | LEE, JAE W | 33d |
| 18849107 | THREE DIMENSIONAL PRINTING PROCESS FLOW MANAGEMENT AND SUPPORT SYSTEMS | GRAHAM, ANDREW D | 53d |
| 17616621 | CRISPR SYSTEM HIGH THROUGHPUT DIAGNOSTIC SYSTEMS AND METHODS | POHNERT, STEVEN C | 53d |
| 18576909 | METHODS FOR DIFFERENTIATING AND SCREENING STEM CELLS | WESTON, ALYSSA G | — |
| 18541680 | METHODS AND COMPOSITIONS FOR PREDICTING AND PREVENTING RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA | DAVIS, BRIAN J | — |
| 18565668 | NOVEL TARGETS FOR ENHANCING ANTI-TUMOR IMMUNITY | ALDARONDO, DASIA ALI | — |
| 18276471 | NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF | SULLIVAN, STEPHANIE LAUREN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628213 | NANOPOROUS ALLOYS | WANG, XIAOBEI | 140d overdue |
| 18688206 | STATOR WITH PERMANENT PROTECTIVE BARRIER SEALING | ANDREWS, MICHAEL | 70d overdue |
| 17085937 | BACTERIAL DEFENSE SYSTEMS AND METHODS OF IDENTIFYING THEREOF | RYAN, DOUGLAS CHARLES | 3d overdue |
| 16756134 | SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING | STEADMAN, DAVID J | 3d overdue |
| 16450852 | NOVEL CRISPR ENZYMES AND SYSTEMS | RAMIREZ, DELIA M | 9d |
| 19329060 | VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES | KUCKLA, ANNA GRACE | 23d |
| 18849107 | THREE DIMENSIONAL PRINTING PROCESS FLOW MANAGEMENT AND SUPPORT SYSTEMS | GRAHAM, ANDREW D | 53d |
| 16772269 | CAS12B SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING | RAMIREZ, DELIA M | 70d |
| Client (Assignee) | Pending OAs |
|---|---|
| MIT | 29 |
| Harvard University | 5 |
| EPAX NORWAY AS | 2 |
| DANA-FARBER CANCER INSTITUTE, INC. | 2 |
| THE GENERAL HOSPITAL CORPORATION | 2 |
| Azul 3D, Inc. | 1 |
| Virginia Tech | 1 |
| Elaphe Propulsion Technologies, Ltd. | 1 |
| The Children's Medical Center Corporation | 1 |
| University of California | 1 |
| Lankem | 1 |
| U.S. Government | 1 |
| Art Unit | Apps |
|---|---|
| 1635 | 5 |
| 1636 | 5 |
| 1683 | 4 |
| 1634 | 3 |
| 1681 | 3 |
| 1656 | 3 |
| 1637 | 3 |
| 1652 | 3 |
| 1633 | 2 |
| 1632 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19329060 | VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES | Epax Norway AS | KUCKLA, ANNA GRACE | 1626 | §103 | Final Rejection | 23d | Pending | Sep 15, 2025 |
| 18965935 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | Massachusetts Institute Of Technology | RYAN, DOUGLAS CHARLES | 1635 | §112 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18849107 | THREE DIMENSIONAL PRINTING PROCESS FLOW MANAGEMENT AND SUPPORT SYSTEMS | Azul 3D, Inc. | GRAHAM, ANDREW D | 1742 | §103§112 | Non-Final OA | 53d | Pending | Sep 20, 2024 |
| 18628213 | NANOPOROUS ALLOYS | VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY | WANG, XIAOBEI | 1784 | §103 | Non-Final OA | 140d overdue | Pending | Apr 05, 2024 |
| 18688206 | STATOR WITH PERMANENT PROTECTIVE BARRIER SEALING | Elaphe Propulsion Technologies, Ltd. | ANDREWS, MICHAEL | 2834 | §102§103 | Final Rejection | 70d overdue | Pending | Feb 29, 2024 |
| 18576909 | METHODS FOR DIFFERENTIATING AND SCREENING STEM CELLS | Massachusetts Institute Of Technology | WESTON, ALYSSA G | 1633 | §101§102§112 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18541680 | METHODS AND COMPOSITIONS FOR PREDICTING AND PREVENTING RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA | DANA-FARBER CANCER INSTITUTE, INC. | DAVIS, BRIAN J | 1614 | §102§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18565668 | NOVEL TARGETS FOR ENHANCING ANTI-TUMOR IMMUNITY | Massachusetts Institute Of Technology | ALDARONDO, DASIA ALI | 1646 | §102§103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18280547 | METHODS OF PREDICTING RESPONSE TO ANTI-TNF BLOCKADE IN INFLAMMATORY BOWEL DISEASE | The Children's Hospital of Philadelphia | HAMA, JOANNE | 1647 | §112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18276471 | NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF | Massachusetts Institute Of Technology | SULLIVAN, STEPHANIE LAUREN | 1635 | §101§102§103§112DP | Non-Final OA | — | Pending | Aug 09, 2023 |
| 18273579 | MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS | The Regents of the University of California | RAHMAN, MASUDUR | 1633 | §102§103§112 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18272158 | COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL | Massachusetts Institute Of Technology | LEITH, NANCY J | 1636 | §103§112DP | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18216135 | COMPOSITION AND METHOD | Lankem Ltd. | FEELY, MICHAEL J | 1766 | §103 | Non-Final OA | 4d overdue | Pending | Jun 29, 2023 |
| 18269813 | TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS | Massachusetts Institute Of Technology | MONTANARI, DAVID A | 1632 | §102§103Other | Non-Final OA | — | Pending | Jun 27, 2023 |
| 18268156 | CORONAVIRUS RAPID DIAGNOSTICS | Massachusetts Institute Of Technology | SALVOZA, M FRANCO G | 1672 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18334074 | TYPE VI CRISPR ORTHOLOGS AND SYSTEMS | President and Fellows of Harvard College | KONOPKA, CATHERINE ANNE | 1635 | DP | Final Rejection | 9d | Pending | Jun 13, 2023 |
| 18249865 | NUCLEIC ACID-GUIDED NUCLEASES AND USE THEREOF | Massachusetts Institute Of Technology | EBBINGHAUS, BRIANA NOEL | 1632 | §101§102§112DP | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18030324 | T-DNA MEDIATED GENETIC MODIFICATION | Massachusetts Institute Of Technology | SU-TOBON, QIWEN NMN | 1636 | §102§103 | Final Rejection | — | Pending | Apr 05, 2023 |
| 18023538 | CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS FOR VIRUS DETECTION | Massachusetts Institute Of Technology | SALMON, KATHERINE D | 1682 | §102§103§112 | Non-Final OA | — | Pending | Feb 27, 2023 |
| 17912889 | COMPOSITIONS AND METHODS FOR ENHANCED LENTIVIRAL PRODUCTION | Massachusetts Institute Of Technology | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103DP | Final Rejection | — | Pending | Sep 20, 2022 |
| 17910497 | NOVEL CAS ENZYMES AND METHODS OF PROFILING SPECIFICITY AND ACTIVITY | Massachusetts Institute Of Technology | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | — | Pending | Sep 09, 2022 |
| 17801815 | NOVEL TYPE IV AND TYPE I CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF | Massachusetts Institute Of Technology | PENNINGTON, KATIE LEIGH | 1634 | §101§102§103§112 | Final Rejection | — | Pending | Aug 24, 2022 |
| 17798248 | FIELD DEPLOYABLE CRISPR-CAS DIAGNOSTICS AND METHODS OF USE THEREOF | Massachusetts Institute Of Technology | PRIEST, AARON A | 1681 | §102§103DP | Non-Final OA | — | Pending | Aug 08, 2022 |
| 17793115 | SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF | Massachusetts Institute Of Technology | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | — | Pending | Jul 15, 2022 |
| 17788781 | GUIDED EXCISION-TRANSPOSITION SYSTEMS | Massachusetts Institute Of Technology | WOOLWINE, SAMUEL C | 1681 | §102§103§112 | Final Rejection | — | Pending | Jun 24, 2022 |
| 17786168 | GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES | Massachusetts Institute Of Technology | LEE, JAE W | 1656 | §102§103§112 | Final Rejection | 33d | Pending | Jun 16, 2022 |
| 17785070 | PROGRAMMABLE DNA NUCLEASE-ASSOCIATED LIGASE AND METHODS OF USE THEREOF | Massachusetts Institute Of Technology | PERSONS, JENNA L | 1637 | §103§112 | Final Rejection | — | Pending | Jun 14, 2022 |
| 17778192 | RETROTRANSPOSONS AND USE THEREOF | Massachusetts Institute Of Technology | ALLEN, SARAH ELIZABETH | 1637 | §102§103§112DP | Non-Final OA | — | Pending | May 19, 2022 |
| 17742503 | CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS AND METHODS OF USE THEREOF | Massachusetts Institute Of Technology | LEITH, NANCY J | 1636 | §112DP | Non-Final OA | — | Pending | May 12, 2022 |
| 17764509 | ENGINEERED MUSCLE TARGETING COMPOSITIONS | Massachusetts Institute Of Technology | CHESTNUT, BARRY A | 1672 | §102§112DPOther | Non-Final OA | 77d | Pending | Mar 28, 2022 |
| 17761641 | COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL | Massachusetts Institute Of Technology | ABBOTT, KODYE LEE | 1634 | §103 | Final Rejection | — | Pending | Mar 18, 2022 |
| 17761292 | NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS | Massachusetts Institute Of Technology | MCLEOD, AFRICA MHAIRIE | 1635 | §102§112 | Final Rejection | — | Pending | Mar 17, 2022 |
| 17640016 | CRISPR EFFECTOR SYSTEM BASED MULTIPLEX CANCER DIAGNOSTICS | DANA-FARBER CANCER INSTITUTE, INC. | HOPPE, EMMA RUTH | 1683 | §103§112DP | Non-Final OA | — | Pending | Mar 03, 2022 |
| 17616621 | CRISPR SYSTEM HIGH THROUGHPUT DIAGNOSTIC SYSTEMS AND METHODS | The General Hospital Corporation | POHNERT, STEVEN C | 1683 | §102§103§112Other | Non-Final OA | 53d | Pending | Dec 03, 2021 |
| 17612245 | NON-CLASS I MULTI-COMPONENT NUCLEIC ACID TARGETING SYSTEMS | Massachusetts Institute Of Technology | REGA, KYLE THOMAS | 1636 | §102§103§112 | Non-Final OA | — | Pending | Nov 18, 2021 |
| 17311600 | VERY LONG CHAIN FATTY ACID COMPOSITIONS | Epax Norway AS | WHITE, DAWANNA SHAR-DAY | 1627 | §101 | Final Rejection | — | Pending | Jun 07, 2021 |
| 17294179 | CRISPR SYSTEM BASED DROPLET DIAGNOSTIC SYSTEMS AND METHODS | The General Hospital Corporation | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Final Rejection | 3d overdue | Pending | May 14, 2021 |
| 17264340 | NOVEL CRISPR ENZYMES AND SYSTEMS | President and Fellows of Harvard College | STEADMAN, DAVID J | 1656 | §102§112 | Final Rejection | — | Pending | Jan 29, 2021 |
| 17085937 | BACTERIAL DEFENSE SYSTEMS AND METHODS OF IDENTIFYING THEREOF | Massachusetts Institute Of Technology | RYAN, DOUGLAS CHARLES | 1635 | §112 | Final Rejection | 3d overdue | Pending | Oct 30, 2020 |
| 16936197 | FUNCTIONALIZED SOLID SUPPORT | Massachusetts Institute Of Technology | BUNKER, AMY M | 1684 | §103 | Final Rejection | 9d overdue | Pending | Jul 22, 2020 |
| 16961820 | CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS | President and Fellows of Harvard College | SCHLOOP, ALLISON ELIZABETH | 1683 | §103§112DP | Non-Final OA | — | Pending | Jul 13, 2020 |
| 16955380 | CRISPR EFFECTOR SYSTEM BASED MULTIPLEX DIAGNOSTICS | President and Fellows of Harvard College | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Non-Final OA | — | Pending | Jun 18, 2020 |
| 16954032 | CAS12A SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING | Massachusetts Institute Of Technology | HUTSON, RICHARD G | 1652 | DP | Final Rejection | 20d | Pending | Jun 15, 2020 |
| 16772222 | CAS12B SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED DNA BASE EDITING | Massachusetts Institute Of Technology | PERSONS, JENNA L | 1637 | §103§112DP | Final Rejection | — | Pending | Jun 12, 2020 |
| 16772269 | CAS12B SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING | Massachusetts Institute Of Technology | RAMIREZ, DELIA M | 1652 | §112 | Non-Final OA | 70d | Pending | Jun 12, 2020 |
| 16756134 | SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING | President and Fellows of Harvard College | STEADMAN, DAVID J | 1656 | DP | Non-Final OA | 3d overdue | Pending | Apr 15, 2020 |
| 16450852 | NOVEL CRISPR ENZYMES AND SYSTEMS | The United States Department of Health and Human Services | RAMIREZ, DELIA M | 1652 | §112 | Non-Final OA | 9d | Pending | Jun 24, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial